# A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

> **NCT04203186** · NA · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Plasmodium Falciparum

## Interventions

- **DRUG:** atovaquone-proguanil

## Key facts

- **NCT ID:** NCT04203186
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03
- **Primary completion:** 2021-06
- **Final completion:** 2021-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was lost due to the COVID19 Pandemic
- **Last updated:** 2020-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04203186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04203186, "A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04203186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*